Tunstall Partners with NHS Gloucestershire in Clinically-led Long Term Conditions Management Programme

Tunstall HealthcareTunstall Healthcare has partnered with NHS Gloucestershire, the primary care trust for Gloucestershire, to implement a large-scale telehealth programme to support the management of long term conditions.

This large-scale telehealth programme aims to provide a managed system of care and response, targeted at patients with long term conditions for whom a timely response will help manage their short and medium term care needs, therefore improving patient outcomes and helping reduce the number of hospital admissions.

Gloucestershire has a population of more than 600,000 people with approximately 6,000 of those people living with a long-term condition (LTC). The use of telehealth complements the changing nature of healthcare to provide care in the right place at the right time and, having run a small scale initiative, NHS Gloucestershire is keen to tap into the expertise of Tunstall to roll out a much larger project to support local people.

The partnership will see Tunstall work with local clinicians across both secondary and primary care to redesign care pathways and implement clinical protocols which will see telehealth as a viable option for managing patients.

As part of the programme, the provision of telehealth will be extended to 2,000 patients with chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), chronic heart disease (CHD) and diabetes.

Dr Will Haynes, a Gloucester-based GP and practice-based commissioning lead for Gloucester who is working closely with Tunstall on this project, said: "The widespread use of telehealth technology will complement other developments across the NHS in Gloucestershire to help reduce referrals to hospitals, help more patients to receive their care within, or as close to, home as possible and help more patients to understand better and self manage their own conditions, within the safety and fabric of telehealth monitoring. As a GP, I welcome the opportunity to use these tools to work with patients to understand their condition."

The provision of telehealth will be extended over a 12-month period commencing in Summer 2011, following a comprehensive, clinically-led development process with Tunstall and Ernst & Young providing full project management and a detailed care pathway redesign programme.

Jon Lowe, Tunstall's Managing Director said: "We are extremely pleased to be working in a strategic partnership with such an innovative team. We are committed to ensuring this large-scale managed telehealth service is a success and I am confident that patients and clinicians will benefit greatly in the future."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market-leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...